Announcements Trials

Browse Landscape

Phase

Status

Completed 25 Terminated 7 Unknown 5 Withdrawn 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 3 Hodgkin Disease 3 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Uveal Melanoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pediatric Brain Tumor 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Follicular 1 Lymphoma 1 Glioblastoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Temozolomide 45 Radiotherapy 17 Magnetic Resonance Spectroscopy 17 Specimen Handling 14 pembrolizumab 12 Bevacizumab 12 Lomustine 9 Radiation 8 fludarabine 7 Cyclophosphamide 7 atezolizumab 4 Biopsy 4 olaparib 3 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Nivolumab 3 Leukapheresis 3 D2C7-(scdsFv)-PE38KDEL 3 Blood Specimen Collection 3 Aminolevulinic Acid 3 regorafenib 2 fluciclovine F-18 2 contrast agent BR1 2 antisecretory factor 2 abemaciclib 2 Restraint, Physical 2 Re-Irradiation 2 Radiation Dose Hypofractionation 2 Palliative Care 2 Oncolytic Virotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioblastoma × Carmustine × Clear all

NCT05052957 2025-11-21

hSTAR GBM

Case Comprehensive Cancer Center

Phase 2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡